Overview

MASCOT : Multicenter Asia Study in Adjuvant Treatment of Colon Cancer With OxaliplaTin/5FU-LV

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Safety & tolerability of FOLFOX4 regimen in the adjuvant treatment of colon cancer in Asian patients
Phase:
Phase 4
Details
Lead Sponsor:
Sanofi
Treatments:
Oxaliplatin